INVO Fertility, Inc. Proceeds from Issuance of Convertible Preferred Stock
INVO Fertility, Inc. (IVF) reported Proceeds from Issuance of Convertible Preferred Stock of $3.20 million for the 9-month period ending 2023-09-30, per its 10-Q filed 2023-11-13.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock · last filed 2023-11-13
- INVO Fertility, Inc. proceeds from issuance of convertible preferred stock for the quarter ending 2023-09-30 was $2.50M.
- INVO Fertility, Inc. proceeds from issuance of convertible preferred stock for the quarter ending 2023-06-30 was $0.00.
- INVO Fertility, Inc. proceeds from issuance of convertible preferred stock for the quarter ending 2023-03-31 was $700.00K.
| Period end | Proceeds from Issuance of Convertible Preferred Stock 3 month | Proceeds from Issuance of Convertible Preferred Stock 6 month | Proceeds from Issuance of Convertible Preferred Stock 9 month |
|---|---|---|---|
| 2023-09-30 | $2.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $2.50M derived: sum of 2 quarters · filed 2023-11-13 | $3.20M 10-Q · filed 2023-11-13 |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $700.00K 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $700.00K 10-Q · filed 2023-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |